Author
Listed:
- Michal Canetti
(The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer
Tel-Aviv University)
- Noam Barda
(ARC Innovation Center, Sheba Medical Center, Tel Hashomer
Software and Information Systems Engineering, Ben-Gurion University of the Negev
Harvard Medical School)
- Mayan Gilboa
(The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer
Tel-Aviv University)
- Victoria Indenbaum
(Tel-Aviv University
Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer)
- Michal Mandelboim
(Tel-Aviv University
Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer)
- Tal Gonen
(The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer
Tel-Aviv University)
- Keren Asraf
(Tel-Aviv University
The Dworman Automated-Mega Laboratory, Sheba Medical Center, Tel-Hashomer)
- Yael Weiss-Ottolenghi
(The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer
Tel-Aviv University)
- Sharon Amit
(Tel-Aviv University
Clinical Microbiology, Sheba Medical Center, Tel Hashomer)
- Ram Doolman
(Tel-Aviv University
The Dworman Automated-Mega Laboratory, Sheba Medical Center, Tel-Hashomer)
- Ella Mendelson
(Tel-Aviv University
Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer)
- Dror Harats
(General Management, Sheba Medical Center, Tel Hashomer)
- Laurence S. Freedman
(Biostatistics and Biomathematics Unit, Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center)
- Yitshak Kreiss
(Tel-Aviv University
General Management, Sheba Medical Center, Tel Hashomer)
- Yaniv Lustig
(Tel-Aviv University
Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health)
- Gili Regev-Yochay
(The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer
Tel-Aviv University)
Abstract
No abstract is available for this item.
Suggested Citation
Michal Canetti & Noam Barda & Mayan Gilboa & Victoria Indenbaum & Michal Mandelboim & Tal Gonen & Keren Asraf & Yael Weiss-Ottolenghi & Sharon Amit & Ram Doolman & Ella Mendelson & Dror Harats & Laure, 2023.
"Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up,"
Nature Communications, Nature, vol. 14(1), pages 1-1, December.
Handle:
RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37338-7
DOI: 10.1038/s41467-023-37338-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37338-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.